Xiaoyu Yang

Dr. Xiaoyu Yang


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2019 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
LTLichan Tao
Lichan Tao
LYLing Yang
Ling Yang
XHXiaoli Huang
Xiaoli Huang
FHFei Hua
Fei Hua
XYXiaoyu Yang
Xiaoyu Yang
Dilated cardiomyopathy (DCM) is an important cause of sudden death and heart failure with an unknown etiology. Recent studies have suggested that long non-coding RNA (lncRNA) can interact with microRNA (miRNA) and indirectly interact with mRNA through competitive endogenous RNA (ceRNA) activities. However, the mechanism of ceRNA in DCM remains unclear. In this study, a miRNA array was first performed using heart samples from DCM patients and healthy controls. For further validation, we conducted real-time quantitative reverse transcription (RT)-PCR using samples from DCM patients and a doxorubicin-induced rodent model of cardiomyopathy, revealing that miR-144-3p and miR-451a were down-regulated, and miR-21-5p was up-regulated. Based on the ceRNA theory, we constructed a global triple network using data from the National Center for Biotechnology Information Gene Expression Omnibus (NCBI-GEO) and our miRNA array. The lncRNA-miRNA-mRNA network comprised 22 lncRNA nodes, 32 mRNA nodes, and 11 miRNA nodes. Hub nodes and the number of relationship pairs were then analyzed, and the results showed that two lncRNAs (NONHSAT001691 and NONHSAT006358) targeting miR-144/451 were highly related to DCM. Then, cluster module and random walk with restart for the ceRNA network were analyzed and identified four lncRNAs (NONHSAT026953/NONHSAT006250/NONHSAT133928/NONHSAT041662) targeting miR-21 that were significantly related to DCM. This study provides a new strategy for research on DCM or other diseases. Furthermore, lncRNA-miRNA pairs may be regarded as candidate diagnostic biomarkers or potential therapeutic targets of DCM.

19 November 2024 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
CHCan Hou
Can Hou
JHJunyu Huo
Junyu Huo
SYSi Yan
Si Yan
FSFei Sun
Fei Sun
XYXiaoyu Yang
Xiaoyu Yang
Heart failure (HF) and cancer share common risk factors and pathophysiological mechanisms, including fibrosis. Identifying biomarkers and therapeutic targets for both conditions is crucial. RNA sequencing data from HF patients were analyzed to identify 12 genes associated with myocardial fibrosis. Validation was performed using public datasets, and functional enrichment analyses were conducted. Gene expression patterns and prognostic value in various cancers were assessed. Fibromodulin (FMOD), Periostin (POSTN), Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP2), Collagen Type I Alpha 1 Chain (COL1A1), Collagen Type VIII Alpha 1 Chain (COL8A1), Asporin (ASPN), and Hemoglobin Subunit Beta (HBB) showed significant dysregulation in heart failure tissues and were implicated in multiple cancer types. Pan-cancer analysis revealed associations between these genes and prognosis. Correlations with cancer-associated fibroblasts were also observed. FMOD, POSTN, LTBP2, COL1A1, COL8A1, ASPN, and HBB are potential biomarkers for HF and cancer with fibrotic microenvironments. Targeting fibrosis may offer novel therapeutic approaches. Further validation and mechanistic studies are needed. This study contributes to understanding HF and cancer at the molecular level and suggests personalized treatment strategies.

23 September 2025 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
SXSu Xingzhou
Su Xingzhou
YWYu Wenji
Yu Wenji
XQXie Qifei
Xie Qifei
SXSong Xuhong
Song Xuhong
WJWang Jianfeng
Wang Jianfeng
YWYuetao Wang
Yuetao Wang

12 August 2025 in Cardiology
Verified
Journal Article
Open access
SYSi Yan
Si Yan
ZFZhichao Fang
Zhichao Fang
XXXin Xue
Xin Xue
CHCan Hou
Can Hou
XYXiaoyu Yang
Xiaoyu Yang
Background: Myocardial infarction (MI) and cancer collectively account for over 50% of global mortality. Recent studies have revealed multiple associations between these two diseases, including chronic inflammation and oxidative stress, with a particular focus on hypoxia-mediated signaling pathways. In ischemic myocardium, oxygen deprivation triggers apoptosis, fibrosis, and pathological tissue reorganization, in the tumor microenvironment (TME), hypoxia drives angiogenesis, metabolic reprogramming, and immune evasion. Therefore, identifying hypoxia-related differentially expressed genes in MI may provide potential therapeutic targets for both conditions. Methods: Sequencing data from MI patients were obtained from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were identified using the “limma” package in R.Weighted gene co-expression network analysis (WGCNA) was then employed to screen for a set of potential hub genes associated with hypoxia. Functional enrichment analysis was performed on these hub genes. The expression levels and stability of the hub genes were subsequently validated in a new dataset. Finally, transcriptional regulatory analysis and immune infiltration analysis were conducted for the hub genes, and their expression levels and prognostic values in various cancers were evaluated. Results: In MI samples, nine genes, namely Immediate Early Response 3 (IER3), Heme Oxygenase 1 (HMOX1), Cyclin Dependent Kinase Inhibitor 1A (CDKN1A), Plasminogen Activator Urokinase Receptor (PLAUR), MAF BZIP Transcription Factor F (MAFF), Solute Carrier Family 2 Member 3 (SLC2A3), Jun Proto-Oncogene (JUN), Transforming Growth Factor Beta Induced (TGFBI), and 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3 (PFKFB3), were found to be significantly dysregulated and were closely associated with the occurrence of various cancers. Pan-cancer analysis further revealed that these genes are correlated with cancer prognosis. Immune analysis also observed their associations with resting CD4+ memory T cells and Gamma Delta T cells in TME. Conclusions: IER3, HMOX1, CDKN1A, PLAUR, MAFF, SLC2A3, JUN, TGFBI, and PFKFB3 are potential biomarkers for MI and cancer. Research on hypoxia-related genes (HRGs) may provide new therapeutic targets for these two diseases.

1 August 2026 in Quantitative Imaging in Medicine and Surgery
Verified
Journal Article
Open access
PDF file
SYSi Yan
Si Yan
FZFeifei Zhang
Feifei Zhang
ZFZhichao Fang
Zhichao Fang
XXXin Xue
Xin Xue
XSXiaoliang Shao
Xiaoliang Shao
XYXiaoyu Yang
Xiaoyu Yang
Background: Identifying obstructive coronary artery disease (OCAD) via non-invasive imaging modalities in patients with suspected unstable angina (UA) holds substantial clinical significance. This study aimed to develop and validate a diagnostic model for OCAD in patients with suspected UA, by leveraging resting 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) myocardial ischemia memory imaging combined with clinical indicators. Methods: We retrospectively analyzed 162 patients with a Global Registry of Acute Coronary Events (GRACE) score ≤140 who presented with chest pain or chest tightness and were clinically suspected of having UA. After collecting clinical indicators, predictive factors were screened using logistic regression. A diagnostic model was constructed using binary logistic regression based on the predictive factors, with internal validation via 1,000 bootstrap resamples. The discriminative ability, calibration, and clinical net benefit of the established model were evaluated by the receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA). Furthermore, the enhancement value of the final model over the basic model was quantified using net reclassification improvement (NRI) and integrated discrimination improvement (IDI). Results: Of the 162 enrolled patients with suspected UA, 89 (54.9%) were diagnosed with OCAD. Six predictors were incorporated into the diagnostic model, including hyperlipidemia, diabetes, typical angina pectoris, 18F-FDG PET results, serum creatinine, and left ventricular ejection fraction (LVEF). The area under the curve (AUC) of the model was 0.89 [95% confidence interval (CI): 0.84–0.94], with a sensitivity of 0.84 and a specificity of 0.81; the Brier score was 0.1319. The Hosmer-Lemeshow goodness-of-fit test revealed good model fit (χ2=6.15, P=0.63). After internal validation via the bootstrap method, the optimism-corrected AUC was 0.87 (95% CI: 0.82–0.93). Calibration curve and DCA demonstrated that the model exhibited satisfactory calibration and promising clinical utility. Conclusions: The OCAD diagnostic model for suspected UA patients, based on resting 18F-FDG PET and clinical indicators, demonstrated excellent diagnostic performance.

25 April 2022 in Frontiers in Genetics
Verified
Journal Article
Open access
LTLichan Tao
Lichan Tao
LYLing Yang
Ling Yang
XHXiaoli Huang
Xiaoli Huang
FHFei Hua
Fei Hua
XYXiaoyu Yang
Xiaoyu Yang
Corrigendum: Reconstruction and Analysis of the lncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA Reveal Functional lncRNAs in Dilated Cardiomyopathy